AIIMS Bhopal hosts Uveitis Meet 2025 to address complex eye disorders

Published on: 

AIIMS Bhopal’s Department of Ophthalmology successfully hosted the Uveitis Meet 2025, a significant super-specialty academic conference in central India, focusing on complex eye conditions, particularly uveitis (inflammation of the eye). The event, which took place recently, drew over 125 delegates from across the country.

The conference featured insightful lectures from six invited experts from renowned institutions. Keynote speakers included Dr. Padmamalini Mahendradas from Narayana Nethralaya, Bengaluru; Dr. Parthopratim Dutta Majumder from Sankara Nethralaya, Chennai; Dr. Alok Sen from Sadguru Netra Chikitsalaya, Chitrakoot; Dr. Dhaivat Shah from Choithram Nethralaya, Indore; and Dr. Anamika Dwivedi from SS Medical College, Rewa. These experts addressed the latest advancements in the diagnosis and treatment of uveitis, facilitating in-depth discussions on the subject.

Dr. Samendra Karkhur, the Organizing Secretary of the event, emphasized that this was the first conference of its kind in central India, attracting expert participation from across the nation. He highlighted the well-equipped facilities at the Department of Ophthalmology at AIIMS Bhopal, which are essential for the diagnosis and management of complex diseases like uveitis.

The event also featured a competitive case presentation session and an engaging quiz for postgraduate students. Dr. Esther, a second-year postgraduate student at AIIMS Bhopal, secured the first position in the case presentation competition. A total of 15 postgraduate students from various institutions in Bhopal participated in this contest.

The event was successfully conducted with the support of Dr. Saroj Gupta, Dr. Priti Singh, Dr. Vidhya Verma, and Dr. Samendra Karkhur.

Prof. (Dr.) Ajai Singh, Executive Director of AIIMS Bhopal, remarked, "AIIMS Bhopal is playing a leading role in every field of medicine and research. Academic events like Uveitis Meet 2025 not only enhance academic excellence but also benefit the general public, as they will no longer need to travel long distances for the treatment of rare eye diseases.

Daily Pioneer
dailypioneer.com